(Q39761109)

14 September 2017

title

The world of dementia beyond 2020. (English)

1 reference

14 September 2017

0 references

8

Philip Scheltens

1 reference

14 September 2017

Steven T Dekosky

3

0 references

Henry Brodaty

1

object named as

Henry Brodaty

1 reference

14 September 2017

9

Bart De Strooper

1 reference

14 September 2017

2

Monique M B Breteler

1 reference

14 September 2017

Pascale Dorenlot

4

1 reference

14 September 2017

Laura Fratiglioni

5

1 reference

14 September 2017

Christoph Hock

6

1 reference

14 September 2017

Paul-Ariel Kenigsberg

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

13 April 2011

1 reference

Journal of the American Geriatrics Society

14 September 2017

published in

1 reference

14 September 2017

volume

59

1 reference

14 September 2017

issue

5

1 reference

14 September 2017

page(s)

923-927

1 reference

An active and socially integrated lifestyle in late life might protect against dementia

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

Methodological issues in primary prevention trials for neurodegenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

A cell biological perspective on Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

The neuronal microRNA system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

An estimate of the total worldwide societal costs of dementia in 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03365.X

10.1111/J.1532-5415.2011.03365.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference